Elsevier Announces the Launch of NanoImpact, a New Multidisciplinary Journal Publishing Research that Focusses on the Impact of Nanomaterials on Human Health and the Environment
Amsterdam, October 27, 2015
Elsevier, a world-leading provider of scientific, technical and medical information products and services, announces the launch of NanoImpact, a new multidisciplinary journal that is devoted to publishing cutting edge research addressing the behavior and impact of nanomaterials on human health and environmental systems.
NanoImpact welcomes article submissions in the following four main areas of research: human nanotoxicology, econanotoxicology, exposure, and risk- and lifecycle assessment. Other topics of research such as the development of methodological and modelling approaches and the development of materials and methods to enhance nanosafety, will also be considered if there is a clear link to four main areas. .
The journal will be under the editorship of: Associate Professor Philip Demokritou, Harvard University, USA; Professor Guibin Jiang, State Key Laboratory of Environmental Chemistry and Ecotoxicology, Chinese Academy of Sciences China (CAS); Professor Jamie R. Lead, University of South Carolina, USA and Professor Bernd Nowack, Swiss Federal Laboratories for Materials Science and Technology (Empa), Switzerland.
Deirdre Dunne, Senior Publisher at Elsevier said of the launch, “With increasing attention on the impact of nanomaterials on human health and the environment, NanoImpact will benefit various groups including scientists, governmental and international organizations as well as the general public. The journal embraces and promotes the increasing multidisciplinary nature of the field of nanosafety through publishing high quality themed issues. We believe that it will be a valuable contribution not only to the field, but also the wider academic community.”
For more information and to submit an article, go to: www.journals.elsevier.com/nanoimpact
Elsevier is a global information analytics business that helps scientists and clinicians to find new answers, reshape human knowledge, and tackle the most urgent human crises. For 140 years, we have partnered with the research world to curate and verify scientific knowledge. Today, we’re committed to bringing that rigor to a new generation of platforms. Elsevier provides digital solutions and tools in the areas of strategic research management, R&D performance, clinical decision support, and professional education; including ScienceDirect, Scopus, SciVal, ClinicalKey and Sherpath. Elsevier publishes over 2,500 digitized journals, including The Lancet and Cell, 39,000 e-book titles and many iconic reference works, including Gray's Anatomy. Elsevier is part of RELX, a global provider of information-based analytics and decision tools for professional and business customers. www.elsevier.com
+ 31 20 485 3870